Partnership based on charity and industry enticements. Institutions in the public health arena, the Accelerator was a public-private Gates’s Covid-19 ACT-AcceleratorĮxpressed a status quo vision for organizing the research, development, manufacture,Īnd distribution of treatments and vaccines. The world’s scientific response to the pandemic.
In April, Bill Gates launched a bold bid to manage The possibility they’d been outmatched and outmaneuvered by the most powerful Advocates for poolingĪnd open science, who seemed ascendant and even unstoppable that winter, confronted Possibility that defined the early days were long gone.
Idea became real in late May with the launch of the WHO Covid-19 Technologyīy then, however, the optimism and sense of Research and organizing it as a “race,” public and private actors would collect researchĪnd associated intellectual property in a global knowledge fund for the duration of the pandemic. Instead of putting up proprietary walls around Their efforts was a plan, started in early March, to create a voluntary intellectual Possibility emboldened forces working to extend the cooperative model. Paper expressed what felt like a hardening conventional wisdom. will be universally and cheaply available,” the Times editorial ized on March 27 that “the world has an overwhelming interest in ensuring Years-has been completed in weeks,” noted the editors of Nature. “Work that would normally have taken months-or possibly even Infectious Diseases collaborated to produce atomic-level maps of the key viral proteins In January and February 2020, a consortium ledīy the National Institutes of Health and the National Institute of Allergy and TheĮarly days featured tantalizing glimpses of an open-science,Ĭooperative pandemic response. “precompetitive” and “no-profit” approaches to development and pricing. Governments spoke of shared interests and global public goods drug companies pledged March, strange but welcome melodies could be heard from unexpected quarters. Global drug system based on proprietary science and market monopolies. Open-science movements hoped the immensity of the pandemic would override a Battle-scarred veterans of the medicines-access and Research and development to manufacturing scale-up-does not seem to haveīut they weren’t alone. Governments would allow intellectual property concerns to slow things down-from That pharmaceutical companies and their allied If the worst came to pass, the expertsĪnd researchers assumed cooperation would define the global response, with the Mentioned in the paper: intellectual property. To assess the merits of treatments and vaccines. The group also drew up plans for global comparative trials overseen by the WHO, The global researchĬommunity would maintain broad and open channels of communication, sinceĬollaboration and information-sharing minimize duplication and accelerate discovery. Premise was that the world would unite against the virus. In preparation for a world upended by the virus then known as 2019-nCoV.ĭocument summarized the state of coronavirus research and proposed ways toĪccelerate the development of diagnostics, treatments, and vaccines. Sense of borrowed time, they spent two days furiously sketching an “R&D Blueprint”
The official pronouncement of a pandemic was still a month out, but theĪgency’s international brain trust knew enough to be worried. On February 11, 2020, public health and infectious disease experts gatheredīy the hundreds at the World Health Organization’s Geneva mothership.
0 kommentar(er)
